APO Research
Talk to an analyst

APO RESEARCH · REPORT

Clinical Trial Imaging

Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.

Selected research

Market Outlook & Growth Opportunities

Global Clinical Trial Imaging Market Outlook and Growth Opportunities 2026

28 December 2025190 pages

Choose your research edition.

Industry ResearchClinical Trial Imaging Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Clinical Trial Imaging Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Clinical Trial Imaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Clinical Trial Imaging Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Clinical Trial Imaging Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.

According to the Segmentation of types, all the market of Clinical Trial Imaging can be divided into In-house Imaging Service and Central Imaging Service. The Central Imaging Service, it holds a comparatively larger share in global market, which accounts for about 69% in 2019.

Based on the Clinical Trial Imaging application, the Clinical Trial Imaging market is sub-segmented into several major Application, like Pharmaceutical Companies, Biotechnology Companies, Academic Institutes, Others, etc. Pharmaceutical Companies and Biotechnology Companies are the most important applications, which holds nearly 1/3 and 1/4 of the market in 2019.

Read the full market overview

From the view of region, North America and Europe have a larger market share in 2019 which account for about 1/3 and 27%, and will witness a stable growth in following years. Asia-Pacific and India hold a big market share also, and they will witness the comparatively bigger market share in the future.

The world TOP 5 players in the Clinical Trial Imaging market are ICON, ERT, McLaren, Bioclinica, Parexel. These Top 5 companies currently account for more than 43% of the total market share and are expected to retain their dominating hold over the market during the forecast period.

This report provides an overview of the global Clinical Trial Imaging market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Clinical Trial Imaging and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Clinical Trial Imaging revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Clinical Trial Imaging market.

Clinical Trial Imaging Segment by Company

ICON

ERT

McLaren

Bioclinica

Parexel

BioTelemetry

ProScan Imaging

Imaging Endpoints

Radiant Sage

Micron, Inc.

Intrinsic Imaging

Median Technologies

Cardiovascular Imaging Technologies

Banook Medical

IXICO

Clinical Trial Imaging Segment by Type

In-house Imaging Service

Central Imaging Service

Clinical Trial Imaging Segment by Application

Pharmaceutical Companies

Biotechnology Companies

Academic Institutes

Others

Clinical Trial Imaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Clinical Trial Imaging status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Clinical Trial Imaging key companies, revenue, market share, and recent developments.

3. To split the Clinical Trial Imaging breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Clinical Trial Imaging market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Clinical Trial Imaging significant trends, drivers, influence factors in global and regions.

6. To analyze Clinical Trial Imaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trial Imaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Clinical Trial Imaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trial Imaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Clinical Trial Imaging industry.

Chapter 3: Detailed analysis of Clinical Trial Imaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Clinical Trial Imaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Clinical Trial Imaging in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Clinical Trial Imaging Industry Trends Table 2. Clinical Trial Imaging Industry Drivers Table 3. Clinical Trial Imaging Industry Opportunities and Challenges Table 4. Clinical Trial Imaging Industry Restraints Table 5. Global Clinical Trial Imaging Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Clinical Trial Imaging Revenue Share by Company (2021-2026) Table 7. Global Clinical Trial Imaging Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Clinical Trial Imaging Key Company Manufacturing Base & Headquarters Table 9. Global Clinical Trial Imaging Company, Product Type & Application Table 10. Global Clinical Trial Imaging Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Clinical Trial Imaging by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of In-house Imaging Service Table 15. Significant Companies of Central Imaging Service Table 16. Global Clinical Trial Imaging Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Clinical Trial Imaging Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Clinical Trial Imaging Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Clinical Trial Imaging Sales Value Share by Type (2021-2026) Table 20. Global Clinical Trial Imaging Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceutical Companies Table 22. Significant Companies of Biotechnology Companies Table 23. Significant Companies of Academic Institutes Table 24. Significant Companies of Others Table 25. Global Clinical Trial Imaging Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Clinical Trial Imaging Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Clinical Trial Imaging Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Clinical Trial Imaging Sales Value Share by Application (2021-2026) Table 29. Global Clinical Trial Imaging Sales Value Share by Application (2027-2032) Table 30. Global Clinical Trial Imaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Clinical Trial Imaging Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Clinical Trial Imaging Sales Value Share by Region (2021-2026) Table 33. Global Clinical Trial Imaging Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Clinical Trial Imaging Sales Value Share by Region (2027-2032) Table 35. Global Clinical Trial Imaging Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Clinical Trial Imaging Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Clinical Trial Imaging Sales Value Market Share by Country (2021-2026) Table 38. Global Clinical Trial Imaging Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Clinical Trial Imaging Sales Value Market Share by Country (2027-2032) Table 40. ICON Company Information Table 41. ICON Business Overview Table 42. ICON Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. ICON Clinical Trial Imaging Product Portfolio Table 44. ICON Recent Development Table 45. ERT Company Information Table 46. ERT Business Overview Table 47. ERT Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. ERT Clinical Trial Imaging Product Portfolio Table 49. ERT Recent Development Table 50. McLaren Company Information Table 51. McLaren Business Overview Table 52. McLaren Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. McLaren Clinical Trial Imaging Product Portfolio Table 54. McLaren Recent Development Table 55. Bioclinica Company Information Table 56. Bioclinica Business Overview Table 57. Bioclinica Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Bioclinica Clinical Trial Imaging Product Portfolio Table 59. Bioclinica Recent Development Table 60. Parexel Company Information Table 61. Parexel Business Overview Table 62. Parexel Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Parexel Clinical Trial Imaging Product Portfolio Table 64. Parexel Recent Development Table 65. BioTelemetry Company Information Table 66. BioTelemetry Business Overview Table 67. BioTelemetry Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. BioTelemetry Clinical Trial Imaging Product Portfolio Table 69. BioTelemetry Recent Development Table 70. ProScan Imaging Company Information Table 71. ProScan Imaging Business Overview Table 72. ProScan Imaging Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. ProScan Imaging Clinical Trial Imaging Product Portfolio Table 74. ProScan Imaging Recent Development Table 75. Imaging Endpoints Company Information Table 76. Imaging Endpoints Business Overview Table 77. Imaging Endpoints Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Imaging Endpoints Clinical Trial Imaging Product Portfolio Table 79. Imaging Endpoints Recent Development Table 80. Radiant Sage Company Information Table 81. Radiant Sage Business Overview Table 82. Radiant Sage Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Radiant Sage Clinical Trial Imaging Product Portfolio Table 84. Radiant Sage Recent Development Table 85. Micron, Inc. Company Information Table 86. Micron, Inc. Business Overview Table 87. Micron, Inc. Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Micron, Inc. Clinical Trial Imaging Product Portfolio Table 89. Micron, Inc. Recent Development Table 90. Intrinsic Imaging Company Information Table 91. Intrinsic Imaging Business Overview Table 92. Intrinsic Imaging Clinical Trial Imaging Sales (), Value (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 93. Intrinsic Imaging Clinical Trial Imaging Product Portfolio Table 94. Intrinsic Imaging Recent Development Table 95. Median Technologies Company Information Table 96. Median Technologies Business Overview Table 97. Median Technologies Clinical Trial Imaging Sales (), Value (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 98. Median Technologies Clinical Trial Imaging Product Portfolio Table 99. Median Technologies Recent Development Table 100. Cardiovascular Imaging Technologies Company Information Table 101. Cardiovascular Imaging Technologies Business Overview Table 102. Cardiovascular Imaging Technologies Clinical Trial Imaging Sales (), Value (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 103. Cardiovascular Imaging Technologies Clinical Trial Imaging Product Portfolio Table 104. Cardiovascular Imaging Technologies Recent Development Table 105. Banook Medical Company Information Table 106. Banook Medical Business Overview Table 107. Banook Medical Clinical Trial Imaging Sales (), Value (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 108. Banook Medical Clinical Trial Imaging Product Portfolio Table 109. Banook Medical Recent Development Table 110. IXICO Company Information Table 111. IXICO Business Overview Table 112. IXICO Clinical Trial Imaging Sales (), Value (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 113. IXICO Clinical Trial Imaging Product Portfolio Table 114. IXICO Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Clinical Trial Imaging Product Image Figure 2. Global Clinical Trial Imaging Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Clinical Trial Imaging Market Size (2021-2032) & (US$ Million) Figure 4. Global Clinical Trial Imaging Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. In-house Imaging Service Image Figure 8. Central Imaging Service Image Figure 9. Global Clinical Trial Imaging Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Clinical Trial Imaging Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Clinical Trial Imaging Sales Value Share by Type (2021-2032) Figure 12. Pharmaceutical Companies Image Figure 13. Biotechnology Companies Image Figure 14. Academic Institutes Image Figure 15. Others Image Figure 16. Global Clinical Trial Imaging Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Clinical Trial Imaging Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Clinical Trial Imaging Sales Value Share by Application (2021-2032) Figure 19. Global Clinical Trial Imaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Clinical Trial Imaging Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Clinical Trial Imaging Sales Value (2021-2032) & (US$ Million) Figure 22. North America Clinical Trial Imaging Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Clinical Trial Imaging Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Clinical Trial Imaging Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Clinical Trial Imaging Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Clinical Trial Imaging Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Clinical Trial Imaging Sales Value (2021-2032) & (US$ Million) Figure 28. South America Clinical Trial Imaging Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Clinical Trial Imaging Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Clinical Trial Imaging Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Clinical Trial Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • In-house Imaging Service
  • Central Imaging Service
Applications
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic Institutes
  • Others
Companies covered
  • ICON
  • ERT
  • McLaren
  • Bioclinica
  • Parexel
  • BioTelemetry
  • ProScan Imaging
  • Imaging Endpoints
  • Radiant Sage
  • Micron, Inc.
  • Intrinsic Imaging
  • Median Technologies
  • Cardiovascular Imaging Technologies
  • Banook Medical
  • IXICO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Clinical Trial Imaging Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Clinical Trial Imaging Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Clinical Trial Imaging Market Dynamics
  1. 2.1 Clinical Trial Imaging Industry Trends
  2. 2.2 Clinical Trial Imaging Industry Drivers
  3. 2.3 Clinical Trial Imaging Industry Opportunities and Challenges
  4. 2.4 Clinical Trial Imaging Industry Restraints
3 Clinical Trial Imaging Market by Company
  1. 3.1 Global Clinical Trial Imaging Company Revenue Ranking in 2025
  2. 3.2 Global Clinical Trial Imaging Revenue by Company (2021-2026)
  3. 3.3 Global Clinical Trial Imaging Company Ranking (2024-2026)
  4. 3.4 Global Clinical Trial Imaging Company Manufacturing Base and Headquarters
  5. 3.5 Global Clinical Trial Imaging Company Product Type and Application
  6. 3.6 Global Clinical Trial Imaging Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Clinical Trial Imaging Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Clinical Trial Imaging Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Clinical Trial Imaging Market by Type
  1. 4.1 Clinical Trial Imaging Type Introduction
  2. 4.1.1 In-house Imaging Service
  3. 4.1.2 Central Imaging Service
  4. 4.2 Global Clinical Trial Imaging Sales Value by Type
  5. 4.2.1 Global Clinical Trial Imaging Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Clinical Trial Imaging Sales Value by Type (2021-2032)
  7. 4.2.3 Global Clinical Trial Imaging Sales Value Share by Type (2021-2032)
5 Clinical Trial Imaging Market by Application
  1. 5.1 Clinical Trial Imaging Application Introduction
  2. 5.1.1 Pharmaceutical Companies
  3. 5.1.2 Biotechnology Companies
  4. 5.1.3 Academic Institutes
  5. 5.1.4 Others
  6. 5.2 Global Clinical Trial Imaging Sales Value by Application
  7. 5.2.1 Global Clinical Trial Imaging Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Clinical Trial Imaging Sales Value by Application (2021-2032)
  9. 5.2.3 Global Clinical Trial Imaging Sales Value Share by Application (2021-2032)
6 Clinical Trial Imaging Regional Value Analysis
  1. 6.1 Global Clinical Trial Imaging Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Clinical Trial Imaging Sales Value by Region (2021-2032)
  3. 6.2.1 Global Clinical Trial Imaging Sales Value by Region: 2021-2026
  4. 6.2.2 Global Clinical Trial Imaging Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Clinical Trial Imaging Sales Value (2021-2032)
  7. 6.3.2 North America Clinical Trial Imaging Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Clinical Trial Imaging Sales Value (2021-2032)
  10. 6.4.2 Europe Clinical Trial Imaging Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Clinical Trial Imaging Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Clinical Trial Imaging Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Clinical Trial Imaging Sales Value (2021-2032)
  16. 6.6.2 South America Clinical Trial Imaging Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Clinical Trial Imaging Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Clinical Trial Imaging Sales Value Share by Country, 2025 VS 2032
7 Clinical Trial Imaging Country-level Value Analysis
  1. 7.1 Global Clinical Trial Imaging Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Clinical Trial Imaging Sales Value by Country (2021-2032)
  3. 7.2.1 Global Clinical Trial Imaging Sales Value by Country (2021-2026)
  4. 7.2.2 Global Clinical Trial Imaging Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Clinical Trial Imaging Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Clinical Trial Imaging Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Clinical Trial Imaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ICON
  2. 8.1.1 ICON Company Information
  3. 8.1.2 ICON Business Overview
  4. 8.1.3 ICON Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ICON Clinical Trial Imaging Product Portfolio
  6. 8.1.5 ICON Recent Developments
  7. 8.2 ERT
  8. 8.2.1 ERT Company Information
  9. 8.2.2 ERT Business Overview
  10. 8.2.3 ERT Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ERT Clinical Trial Imaging Product Portfolio
  12. 8.2.5 ERT Recent Developments
  13. 8.3 McLaren
  14. 8.3.1 McLaren Company Information
  15. 8.3.2 McLaren Business Overview
  16. 8.3.3 McLaren Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  17. 8.3.4 McLaren Clinical Trial Imaging Product Portfolio
  18. 8.3.5 McLaren Recent Developments
  19. 8.4 Bioclinica
  20. 8.4.1 Bioclinica Company Information
  21. 8.4.2 Bioclinica Business Overview
  22. 8.4.3 Bioclinica Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bioclinica Clinical Trial Imaging Product Portfolio
  24. 8.4.5 Bioclinica Recent Developments
  25. 8.5 Parexel
  26. 8.5.1 Parexel Company Information
  27. 8.5.2 Parexel Business Overview
  28. 8.5.3 Parexel Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Parexel Clinical Trial Imaging Product Portfolio
  30. 8.5.5 Parexel Recent Developments
  31. 8.6 BioTelemetry
  32. 8.6.1 BioTelemetry Company Information
  33. 8.6.2 BioTelemetry Business Overview
  34. 8.6.3 BioTelemetry Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BioTelemetry Clinical Trial Imaging Product Portfolio
  36. 8.6.5 BioTelemetry Recent Developments
  37. 8.7 ProScan Imaging
  38. 8.7.1 ProScan Imaging Company Information
  39. 8.7.2 ProScan Imaging Business Overview
  40. 8.7.3 ProScan Imaging Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ProScan Imaging Clinical Trial Imaging Product Portfolio
  42. 8.7.5 ProScan Imaging Recent Developments
  43. 8.8 Imaging Endpoints
  44. 8.8.1 Imaging Endpoints Company Information
  45. 8.8.2 Imaging Endpoints Business Overview
  46. 8.8.3 Imaging Endpoints Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Imaging Endpoints Clinical Trial Imaging Product Portfolio
  48. 8.8.5 Imaging Endpoints Recent Developments
  49. 8.9 Radiant Sage
  50. 8.9.1 Radiant Sage Company Information
  51. 8.9.2 Radiant Sage Business Overview
  52. 8.9.3 Radiant Sage Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Radiant Sage Clinical Trial Imaging Product Portfolio
  54. 8.9.5 Radiant Sage Recent Developments
  55. 8.10 Micron, Inc.
  56. 8.10.1 Micron, Inc. Company Information
  57. 8.10.2 Micron, Inc. Business Overview
  58. 8.10.3 Micron, Inc. Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Micron, Inc. Clinical Trial Imaging Product Portfolio
  60. 8.10.5 Micron, Inc. Recent Developments
  61. 8.11 Intrinsic Imaging
  62. 8.11.1 Intrinsic Imaging Company Information
  63. 8.11.2 Intrinsic Imaging Business Overview
  64. 8.11.3 Intrinsic Imaging Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Intrinsic Imaging Clinical Trial Imaging Product Portfolio
  66. 8.11.5 Intrinsic Imaging Recent Developments
  67. 8.12 Median Technologies
  68. 8.12.1 Median Technologies Company Information
  69. 8.12.2 Median Technologies Business Overview
  70. 8.12.3 Median Technologies Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Median Technologies Clinical Trial Imaging Product Portfolio
  72. 8.12.5 Median Technologies Recent Developments
  73. 8.13 Cardiovascular Imaging Technologies
  74. 8.13.1 Cardiovascular Imaging Technologies Company Information
  75. 8.13.2 Cardiovascular Imaging Technologies Business Overview
  76. 8.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cardiovascular Imaging Technologies Clinical Trial Imaging Product Portfolio
  78. 8.13.5 Cardiovascular Imaging Technologies Recent Developments
  79. 8.14 Banook Medical
  80. 8.14.1 Banook Medical Company Information
  81. 8.14.2 Banook Medical Business Overview
  82. 8.14.3 Banook Medical Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Banook Medical Clinical Trial Imaging Product Portfolio
  84. 8.14.5 Banook Medical Recent Developments
  85. 8.15 IXICO
  86. 8.15.1 IXICO Company Information
  87. 8.15.2 IXICO Business Overview
  88. 8.15.3 IXICO Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  89. 8.15.4 IXICO Clinical Trial Imaging Product Portfolio
  90. 8.15.5 IXICO Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst